Global Metastatic Melanoma Drug Market Research Report 2021

Publisher Name :
Date: 11-Jan-2021
No. of pages: 118
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- AGI-134

- ALT-801

- ALT-803

- AMG-232

- Others

Segment by Application

- Hospital

- Clinic

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Merck & Co., Inc.

- Merck KGaA

- Millennium Pharmaceuticals, Inc.

- Morphotek, Inc.

- NewLink Genetics Corporation

- Novartis AG

- Omeros Corporation

- Oncolytics Biotech Inc.

- OncoSec Medical Inc.

- Ono Pharmaceutical Co., Ltd.

- Pfizer Inc.

- Pharmis Biofarmaceutica, Lda.

- Philogen S.p.A.

- Plexxikon Inc.

Global Metastatic Melanoma Drug Market Research Report 2021

Table of Contents
1 Metastatic Melanoma Drug Market Overview
1.1 Product Overview and Scope of Metastatic Melanoma Drug
1.2 Metastatic Melanoma Drug Segment by Type
1.2.1 Global Metastatic Melanoma Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 AGI-134
1.2.3 ALT-801
1.2.4 ALT-803
1.2.5 AMG-232
1.2.6 Others
1.3 Metastatic Melanoma Drug Segment by Application
1.3.1 Metastatic Melanoma Drug Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Metastatic Melanoma Drug Market Size Estimates and Forecasts
1.4.1 Global Metastatic Melanoma Drug Revenue 2016-2027
1.4.2 Global Metastatic Melanoma Drug Sales 2016-2027
1.4.3 Metastatic Melanoma Drug Market Size by Region: 2016 Versus 2021 Versus 2027
2 Metastatic Melanoma Drug Market Competition by Manufacturers
2.1 Global Metastatic Melanoma Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Metastatic Melanoma Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Metastatic Melanoma Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Metastatic Melanoma Drug Manufacturing Sites, Area Served, Product Type
2.5 Metastatic Melanoma Drug Market Competitive Situation and Trends
2.5.1 Metastatic Melanoma Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Metastatic Melanoma Drug Players Market Share by Revenue
2.5.3 Global Metastatic Melanoma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Metastatic Melanoma Drug Retrospective Market Scenario by Region
3.1 Global Metastatic Melanoma Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Metastatic Melanoma Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Metastatic Melanoma Drug Market Facts & Figures by Country
3.3.1 North America Metastatic Melanoma Drug Sales by Country
3.3.2 North America Metastatic Melanoma Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Metastatic Melanoma Drug Market Facts & Figures by Country
3.4.1 Europe Metastatic Melanoma Drug Sales by Country
3.4.2 Europe Metastatic Melanoma Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Metastatic Melanoma Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Metastatic Melanoma Drug Sales by Region
3.5.2 Asia Pacific Metastatic Melanoma Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Metastatic Melanoma Drug Market Facts & Figures by Country
3.6.1 Latin America Metastatic Melanoma Drug Sales by Country
3.6.2 Latin America Metastatic Melanoma Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Metastatic Melanoma Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Metastatic Melanoma Drug Sales by Country
3.7.2 Middle East and Africa Metastatic Melanoma Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Metastatic Melanoma Drug Historic Market Analysis by Type
4.1 Global Metastatic Melanoma Drug Sales Market Share by Type (2016-2021)
4.2 Global Metastatic Melanoma Drug Revenue Market Share by Type (2016-2021)
4.3 Global Metastatic Melanoma Drug Price by Type (2016-2021)
5 Global Metastatic Melanoma Drug Historic Market Analysis by Application
5.1 Global Metastatic Melanoma Drug Sales Market Share by Application (2016-2021)
5.2 Global Metastatic Melanoma Drug Revenue Market Share by Application (2016-2021)
5.3 Global Metastatic Melanoma Drug Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Merck & Co., Inc.
6.1.1 Merck & Co., Inc. Corporation Information
6.1.2 Merck & Co., Inc. Description and Business Overview
6.1.3 Merck & Co., Inc. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck & Co., Inc. Product Portfolio
6.1.5 Merck & Co., Inc. Recent Developments/Updates
6.2 Merck KGaA
6.2.1 Merck KGaA Corporation Information
6.2.2 Merck KGaA Description and Business Overview
6.2.3 Merck KGaA Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck KGaA Product Portfolio
6.2.5 Merck KGaA Recent Developments/Updates
6.3 Millennium Pharmaceuticals, Inc.
6.3.1 Millennium Pharmaceuticals, Inc. Corporation Information
6.3.2 Millennium Pharmaceuticals, Inc. Description and Business Overview
6.3.3 Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Millennium Pharmaceuticals, Inc. Product Portfolio
6.3.5 Millennium Pharmaceuticals, Inc. Recent Developments/Updates
6.4 Morphotek, Inc.
6.4.1 Morphotek, Inc. Corporation Information
6.4.2 Morphotek, Inc. Description and Business Overview
6.4.3 Morphotek, Inc. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Morphotek, Inc. Product Portfolio
6.4.5 Morphotek, Inc. Recent Developments/Updates
6.5 NewLink Genetics Corporation
6.5.1 NewLink Genetics Corporation Corporation Information
6.5.2 NewLink Genetics Corporation Description and Business Overview
6.5.3 NewLink Genetics Corporation Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 NewLink Genetics Corporation Product Portfolio
6.5.5 NewLink Genetics Corporation Recent Developments/Updates
6.6 Novartis AG
6.6.1 Novartis AG Corporation Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Novartis AG Product Portfolio
6.6.5 Novartis AG Recent Developments/Updates
6.7 Omeros Corporation
6.6.1 Omeros Corporation Corporation Information
6.6.2 Omeros Corporation Description and Business Overview
6.6.3 Omeros Corporation Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Omeros Corporation Product Portfolio
6.7.5 Omeros Corporation Recent Developments/Updates
6.8 Oncolytics Biotech Inc.
6.8.1 Oncolytics Biotech Inc. Corporation Information
6.8.2 Oncolytics Biotech Inc. Description and Business Overview
6.8.3 Oncolytics Biotech Inc. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Oncolytics Biotech Inc. Product Portfolio
6.8.5 Oncolytics Biotech Inc. Recent Developments/Updates
6.9 OncoSec Medical Inc.
6.9.1 OncoSec Medical Inc. Corporation Information
6.9.2 OncoSec Medical Inc. Description and Business Overview
6.9.3 OncoSec Medical Inc. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2016-2021)
6.9.4 OncoSec Medical Inc. Product Portfolio
6.9.5 OncoSec Medical Inc. Recent Developments/Updates
6.10 Ono Pharmaceutical Co., Ltd.
6.10.1 Ono Pharmaceutical Co., Ltd. Corporation Information
6.10.2 Ono Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Ono Pharmaceutical Co., Ltd. Product Portfolio
6.10.5 Ono Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Pfizer Inc.
6.11.1 Pfizer Inc. Corporation Information
6.11.2 Pfizer Inc. Metastatic Melanoma Drug Description and Business Overview
6.11.3 Pfizer Inc. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Pfizer Inc. Product Portfolio
6.11.5 Pfizer Inc. Recent Developments/Updates
6.12 Pharmis Biofarmaceutica, Lda.
6.12.1 Pharmis Biofarmaceutica, Lda. Corporation Information
6.12.2 Pharmis Biofarmaceutica, Lda. Metastatic Melanoma Drug Description and Business Overview
6.12.3 Pharmis Biofarmaceutica, Lda. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Pharmis Biofarmaceutica, Lda. Product Portfolio
6.12.5 Pharmis Biofarmaceutica, Lda. Recent Developments/Updates
6.13 Philogen S.p.A.
6.13.1 Philogen S.p.A. Corporation Information
6.13.2 Philogen S.p.A. Metastatic Melanoma Drug Description and Business Overview
6.13.3 Philogen S.p.A. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Philogen S.p.A. Product Portfolio
6.13.5 Philogen S.p.A. Recent Developments/Updates
6.14 Plexxikon Inc.
6.14.1 Plexxikon Inc. Corporation Information
6.14.2 Plexxikon Inc. Metastatic Melanoma Drug Description and Business Overview
6.14.3 Plexxikon Inc. Metastatic Melanoma Drug Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Plexxikon Inc. Product Portfolio
6.14.5 Plexxikon Inc. Recent Developments/Updates
7 Metastatic Melanoma Drug Manufacturing Cost Analysis
7.1 Metastatic Melanoma Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Metastatic Melanoma Drug
7.4 Metastatic Melanoma Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Metastatic Melanoma Drug Distributors List
8.3 Metastatic Melanoma Drug Customers
9 Metastatic Melanoma Drug Market Dynamics
9.1 Metastatic Melanoma Drug Industry Trends
9.2 Metastatic Melanoma Drug Growth Drivers
9.3 Metastatic Melanoma Drug Market Challenges
9.4 Metastatic Melanoma Drug Market Restraints
10 Global Market Forecast
10.1 Metastatic Melanoma Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Metastatic Melanoma Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Metastatic Melanoma Drug by Type (2022-2027)
10.2 Metastatic Melanoma Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Metastatic Melanoma Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Metastatic Melanoma Drug by Application (2022-2027)
10.3 Metastatic Melanoma Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Metastatic Melanoma Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Metastatic Melanoma Drug by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Metastatic Melanoma Drug Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Metastatic Melanoma Drug Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Metastatic Melanoma Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Metastatic Melanoma Drug Covered in This Study
Table 5. Global Metastatic Melanoma Drug Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Metastatic Melanoma Drug Sales Share by Manufacturers (2016-2021)
Table 7. Global Metastatic Melanoma Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Metastatic Melanoma Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Metastatic Melanoma Drug Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Metastatic Melanoma Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Metastatic Melanoma Drug Product Type
Table 12. Global Metastatic Melanoma Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Metastatic Melanoma Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Melanoma Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Metastatic Melanoma Drug Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Metastatic Melanoma Drug Sales Market Share by Region (2016-2021)
Table 17. Global Metastatic Melanoma Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Metastatic Melanoma Drug Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Metastatic Melanoma Drug Sales Market Share by Country (2016-2021)
Table 20. North America Metastatic Melanoma Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Metastatic Melanoma Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Metastatic Melanoma Drug Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Metastatic Melanoma Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Metastatic Melanoma Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Metastatic Melanoma Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Metastatic Melanoma Drug Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Metastatic Melanoma Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Metastatic Melanoma Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Metastatic Melanoma Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Metastatic Melanoma Drug Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Metastatic Melanoma Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Metastatic Melanoma Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Metastatic Melanoma Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Metastatic Melanoma Drug Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Metastatic Melanoma Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Metastatic Melanoma Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Metastatic Melanoma Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Metastatic Melanoma Drug Sales (K Pcs) by Type (2016-2021)
Table 39. Global Metastatic Melanoma Drug Sales Market Share by Type (2016-2021)
Table 40. Global Metastatic Melanoma Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Metastatic Melanoma Drug Revenue Share by Type (2016-2021)
Table 42. Global Metastatic Melanoma Drug Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Metastatic Melanoma Drug Sales (K Pcs) by Application (2016-2021)
Table 44. Global Metastatic Melanoma Drug Sales Market Share by Application (2016-2021)
Table 45. Global Metastatic Melanoma Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Metastatic Melanoma Drug Revenue Share by Application (2016-2021)
Table 47. Global Metastatic Melanoma Drug Price (USD/Pcs) by Application (2016-2021)
Table 48. Merck & Co., Inc. Corporation Information
Table 49. Merck & Co., Inc. Description and Business Overview
Table 50. Merck & Co., Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Merck & Co., Inc. Metastatic Melanoma Drug Product
Table 52. Merck & Co., Inc. Recent Developments/Updates
Table 53. Merck KGaA Corporation Information
Table 54. Merck KGaA Description and Business Overview
Table 55. Merck KGaA Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Merck KGaA Metastatic Melanoma Drug Product
Table 57. Merck KGaA Recent Developments/Updates
Table 58. Millennium Pharmaceuticals, Inc. Corporation Information
Table 59. Millennium Pharmaceuticals, Inc. Description and Business Overview
Table 60. Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Product
Table 62. Millennium Pharmaceuticals, Inc. Recent Developments/Updates
Table 63. Morphotek, Inc. Corporation Information
Table 64. Morphotek, Inc. Description and Business Overview
Table 65. Morphotek, Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Morphotek, Inc. Metastatic Melanoma Drug Product
Table 67. Morphotek, Inc. Recent Developments/Updates
Table 68. NewLink Genetics Corporation Corporation Information
Table 69. NewLink Genetics Corporation Description and Business Overview
Table 70. NewLink Genetics Corporation Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. NewLink Genetics Corporation Metastatic Melanoma Drug Product
Table 72. NewLink Genetics Corporation Recent Developments/Updates
Table 73. Novartis AG Corporation Information
Table 74. Novartis AG Description and Business Overview
Table 75. Novartis AG Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Novartis AG Metastatic Melanoma Drug Product
Table 77. Novartis AG Recent Developments/Updates
Table 78. Omeros Corporation Corporation Information
Table 79. Omeros Corporation Description and Business Overview
Table 80. Omeros Corporation Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Omeros Corporation Metastatic Melanoma Drug Product
Table 82. Omeros Corporation Recent Developments/Updates
Table 83. Oncolytics Biotech Inc. Corporation Information
Table 84. Oncolytics Biotech Inc. Description and Business Overview
Table 85. Oncolytics Biotech Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Oncolytics Biotech Inc. Metastatic Melanoma Drug Product
Table 87. Oncolytics Biotech Inc. Recent Developments/Updates
Table 88. OncoSec Medical Inc. Corporation Information
Table 89. OncoSec Medical Inc. Description and Business Overview
Table 90. OncoSec Medical Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. OncoSec Medical Inc. Metastatic Melanoma Drug Product
Table 92. OncoSec Medical Inc. Recent Developments/Updates
Table 93. Ono Pharmaceutical Co., Ltd. Corporation Information
Table 94. Ono Pharmaceutical Co., Ltd. Description and Business Overview
Table 95. Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Product
Table 97. Ono Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 98. Pfizer Inc. Corporation Information
Table 99. Pfizer Inc. Description and Business Overview
Table 100. Pfizer Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Pfizer Inc. Metastatic Melanoma Drug Product
Table 102. Pfizer Inc. Recent Developments/Updates
Table 103. Pharmis Biofarmaceutica, Lda. Corporation Information
Table 104. Pharmis Biofarmaceutica, Lda. Description and Business Overview
Table 105. Pharmis Biofarmaceutica, Lda. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Pharmis Biofarmaceutica, Lda. Metastatic Melanoma Drug Product
Table 107. Pharmis Biofarmaceutica, Lda. Recent Developments/Updates
Table 108. Philogen S.p.A. Corporation Information
Table 109. Philogen S.p.A. Description and Business Overview
Table 110. Philogen S.p.A. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Philogen S.p.A. Metastatic Melanoma Drug Product
Table 112. Philogen S.p.A. Recent Developments/Updates
Table 113. Plexxikon Inc. Corporation Information
Table 114. Plexxikon Inc. Description and Business Overview
Table 115. Plexxikon Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. Plexxikon Inc. Metastatic Melanoma Drug Product
Table 117. Plexxikon Inc. Recent Developments/Updates
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Metastatic Melanoma Drug Distributors List
Table 121. Metastatic Melanoma Drug Customers List
Table 122. Metastatic Melanoma Drug Market Trends
Table 123. Metastatic Melanoma Drug Growth Drivers
Table 124. Metastatic Melanoma Drug Market Restraints
Table 125. Global Metastatic Melanoma Drug Sales Forecast by Type (2022-2027) & (K Pcs)
Table 126. Global Metastatic Melanoma Drug Sales Market Share Forecast by Type (2022-2027)
Table 127. Global Metastatic Melanoma Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 128. Global Metastatic Melanoma Drug Revenue Market Share Forecast by Type (2022-2027)
Table 129. Global Metastatic Melanoma Drug Sales Forecast by Application (2022-2027) & (K Pcs)
Table 130. Global Metastatic Melanoma Drug Sales Market Share Forecast by Application (2022-2027)
Table 131. Global Metastatic Melanoma Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 132. Global Metastatic Melanoma Drug Revenue Market Share Forecast by Application (2022-2027)
Table 133. Global Metastatic Melanoma Drug Sales Forecast by Region (2022-2027) & (K Pcs)
Table 134. Global Metastatic Melanoma Drug Sales Market Share Forecast by Region (2022-2027)
Table 135. Global Metastatic Melanoma Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 136. Global Metastatic Melanoma Drug Revenue Market Share Forecast by Region (2022-2027)
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Metastatic Melanoma Drug
Figure 2. Global Metastatic Melanoma Drug Market Share by Type in 2020 & 2027
Figure 3. AGI-134 Product Picture
Figure 4. ALT-801 Product Picture
Figure 5. ALT-803 Product Picture
Figure 6. AMG-232 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Metastatic Melanoma Drug Market Share by Application in 2020 & 2027
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Metastatic Melanoma Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Metastatic Melanoma Drug Market Size 2016-2027 (US$ Million)
Figure 14. Global Metastatic Melanoma Drug Sales 2016-2027 (K Pcs)
Figure 15. Global Metastatic Melanoma Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Metastatic Melanoma Drug Sales Share by Manufacturers in 2020
Figure 17. Global Metastatic Melanoma Drug Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Metastatic Melanoma Drug Players: Market Share by Revenue in 2020
Figure 19. Metastatic Melanoma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Metastatic Melanoma Drug Sales Market Share by Region (2016-2021)
Figure 21. Global Metastatic Melanoma Drug Sales Market Share by Region in 2020
Figure 22. Global Metastatic Melanoma Drug Revenue Market Share by Region (2016-2021)
Figure 23. Global Metastatic Melanoma Drug Revenue Market Share by Region in 2020
Figure 24. U.S. Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Metastatic Melanoma Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Metastatic Melanoma Drug by Type (2016-2021)
Figure 49. Sales Market Share of Metastatic Melanoma Drug by Application (2016-2021)
Figure 50. Sales Market Share of Metastatic Melanoma Drug by Application in 2020
Figure 51. Revenue Share of Metastatic Melanoma Drug by Application (2016-2021)
Figure 52. Revenue Share of Metastatic Melanoma Drug by Application in 2020
Figure 53. Manufacturing Cost Structure of Metastatic Melanoma Drug
Figure 54. Manufacturing Process Analysis of Metastatic Melanoma Drug
Figure 55. Metastatic Melanoma Drug Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
  • Global Bone Putty Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 96
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Orthopedic Surgery - Dental Surgery Segment by Application - Hospitals - Ambulatory S......
  • Global Chronic Pain Treatment Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 120
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Drugs - Devices Segment by Application - Hospitals - Clinics - Nursing Homes......
  • Global Prothrombin Complex Concentrates Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 92
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 3F Prothrombin Complex Concentrates - 4F Prothrombin Complex Concentrates Segment by Application......
  • Global Urology Drugs Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 98
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - ? (alpha) Blockers - 5 ?-reductase Inhibitors Segment by Application - Hospital - Cli......
  • Global Metoprolol Succinate Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 25mg - 50mg - 100mg - 200mg Segment by Application - Hypertension - Ang......
  • Global Prefilled Formalin Vials Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 96
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Below 10 mL - 10 - 20 mL - 20 - 40 mL - 40 - 60 mL - 60 - 90 mL - 90 - 500 mL -......
  • Global Sustained Release Excipients Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Gelatin - Polymers - Minerals - Sugars - Alcohol - Chitosan Segment by ......
  • Global Dermal Filler and Botolinum Toxin Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 121
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Hyaluronic Acid Based Fillers - Non-Hyaluronic Acid Based Fillers - Botulinum Toxin Segment ......
  • Global Branded Generics Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Oral - Parenteral - Topical - Other Segment by Application - Oncology -......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs